MENU
TIL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Instil Bio (TIL) Ownership - Who owns Instil Bio?
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer... Show more
Industry: #Precious Metals
Profile
Industry
Precious Metals
Address
3963 Maple Avenue
Phone
+1 972 499-3350
Employees
49
Web
https://www.instilbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
150.68M
P/E Ratio
N/A
Total Cash
103.65M
Projected Growth
N/A
Total Debt
86.67M
Revenue
N/A
Risk (Beta)
2.29
Dividend Yield
N/A
Total Cash/Share
15.80
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TIL
Capitalization
151M
P/E Ratio
N/A
Risk (Beta)
2.29
Dividend Yield
N/A
Total Cash
104M
Total Cash/Share
15.80
Total Debt
86.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
145M
P/B Ratio
1.04
Cash Flow
N/A
Earnings
-11.97
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
30.33
Current Revenue Per Employee
346.67
Dividends Per Share - Security
N/A
EBITDA
-67.77M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.70
Shares Held By Institutions
67.9M
Shares Outstanding - Current
6.56M
Total Liabilities
92.5M
Total Volume MTD
N/A
Value
1
Gain YTD
20.325
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company engaged in the reinsurance business
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Precious Metals
Address
3963 Maple Avenue
Phone
+1 972 499-3350
Employees
49
Web
https://www.instilbio.com